Literature DB >> 16967447

High expressions of CD105 and VEGF in early oral cancer predict potential cervical metastasis.

Chih-Yen Chien1, Chih-Ying Su, Chung-Feng Hwang, Hui-Ching Chuang, Ching-Mei Chen, Chao-Cheng Huang.   

Abstract

BACKGROUND AND OBJECTIVES: Although elective neck dissection has become a popular treatment modality for early oral cancer among most head and neck surgeons, a large portion of patients revealed pathological N0 postoperatively. Our study is aimed to evaluate the expressions of the angiogenic factors, vascular endothelial growth factor (VEGF), and CD105 (endoglin) on the prediction of neck metastasis for clinical N0 patients in early oral cancer. PATIENTS AND METHODS: Between July 1996 and July 2005, the preoperative biopsy specimens among 176 patients who underwent surgical treatment for early oral cancer were retrieved for the immunohistochemical study for VEGF and CD105.
RESULTS: High expressions of CD105 and VEGF significantly correlated with positive nodal metastasis, respectively (P<0.001). The expression of CD105 also significantly correlated with that of VEGF (P<0.001). Furthermore, the sensitivity and specificity for prediction of cervical metastasis by high expressions of CD105 versus VEGF were 81.8% and 97.7% versus 93.2% and 72%, respectively. Low expression of CD105 and VEGF also significantly correlated with higher survival rate, respectively (P<0.001).
CONCLUSIONS: Besides the image studies, the expressions of both CD105 and VEGF could be useful to guide the elective treatment for clinical N0 neck in early oral cancer. Copyright (c) 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16967447     DOI: 10.1002/jso.20546

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  20 in total

Review 1.  Current status of oral cancer treatment strategies: surgical treatments for oral squamous cell carcinoma.

Authors:  Ken Omura
Journal:  Int J Clin Oncol       Date:  2014-04-01       Impact factor: 3.402

Review 2.  Correlation of expression of hypoxia-related proteins with prognosis in oral squamous cell carcinoma patients.

Authors:  A W Eckert; M Kappler; J Schubert; H Taubert
Journal:  Oral Maxillofac Surg       Date:  2012-05-17

Review 3.  Neck dissection: present and future?

Authors:  Alfio Ferlito; Carl E Silver; Alessandra Rinaldo
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-06       Impact factor: 2.503

4.  VEGF expression and angiogenesis in oral squamous cell carcinoma: an immunohistochemical and morphometric study.

Authors:  Claudiu Mărgăritescu; Daniel Pirici; Alin Stîngă; Cristiana Simionescu; Marius Raica; Laurentiu Mogoantă; Alex Stepan; Domenico Ribatti
Journal:  Clin Exp Med       Date:  2010-04-08       Impact factor: 3.984

5.  Expression of Endoglin (CD-105) and Microvessel Density in Oral Dysplasia and Squamous Cell Carcinoma.

Authors:  Maharudrappa Basnaker; Shashikanth Sr; Satish Bnvs
Journal:  J Clin Diagn Res       Date:  2014-09-20

Review 6.  Angiogenin-mediated ribosomal RNA transcription as a molecular target for treatment of head and neck squamous cell carcinoma.

Authors:  Lili Chen; Guo-fu Hu
Journal:  Oral Oncol       Date:  2010-07-24       Impact factor: 5.337

7.  Assessment of angiogenesis by CD105 antigen in epithelial salivary gland neoplasms with diverse metastatic behavior.

Authors:  Sergio V Cardoso; Kelen Christine N Souza; Paulo R Faria; Ana Lucia A Eisenberg; Fernando L Dias; Adriano M Loyola
Journal:  BMC Cancer       Date:  2009-11-04       Impact factor: 4.430

8.  Correlation of matrix metalloproteinase suppressor genes RECK, VEGF, and CD105 with angiogenesis and biological behavior in esophageal squamous cell carcinoma.

Authors:  Sheng-Lei Li; Dong-Ling Gao; Zhi-Hua Zhao; Zong-Wen Liu; Qiu-Min Zhao; Jin-Xia Yu; Kui-Sheng Chen; Yun-Han Zhang
Journal:  World J Gastroenterol       Date:  2007-12-07       Impact factor: 5.742

9.  Prognostic significance of VEGF immunohistochemical expression in oral cancer: a meta-analysis of the literature.

Authors:  Su-Feng Zhao; Xu-Dong Yang; Ming-Xing Lu; Guo-Wen Sun; Yu-Xin Wang; Yin-Kai Zhang; Yu-Mei Pu; En-Yi Tang
Journal:  Tumour Biol       Date:  2013-06-05

10.  ALK5 phosphorylation of the endoglin cytoplasmic domain regulates Smad1/5/8 signaling and endothelial cell migration.

Authors:  Bridgette N Ray; Nam Y Lee; Tam How; Gerard C Blobe
Journal:  Carcinogenesis       Date:  2009-12-30       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.